News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Scioderm
NEWS
NEWS
Scioderm was acquired by Amicus Therapeutics in September 2015.
Deals
Amicus Snaps up Scioderm and its Lead EB Drug in Deal Worth $847 Million
August 31, 2015
·
2 min read
Bio NC
Scioderm Locks In $20 Million Series B
December 18, 2014
·
2 min read
IN THE PRESS
Bio NC
Scioderm Closes $16 Million in Series A Financing
April 26, 2013
·
5 min read
Bio NC
Scioderm’s Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA
February 14, 2013
·
3 min read
Drug Development
Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children With Epidermolysis Bullosa (EB)
June 20, 2012
·
4 min read
AWARDS
